UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study

Journal of clinical pharmacology, 2019-01, Vol.59 (1), p.90-97

2019

Volltextzugriff (PDF)

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Antimicrobial Agents and Chemotherapy, 1998-03, Vol.42 (3), p.521-527

1998

Volltextzugriff (PDF)

Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

Antimicrobial Agents and Chemotherapy, 2007-09, Vol.51 (9), p.3063-3066

2007

Volltextzugriff (PDF)

Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers

Clinical pharmacokinetics, 2007-01, Vol.46 (7), p.589-598

2007

Volltextzugriff (PDF)

Effect of Telavancin on the Pharmacokinetics of the Cytochrome P450 3A Probe Substrate Midazolam: A Randomized, Double-Blind, Crossover Study in Healthy Subjects

Pharmacotherapy, 2010-02, Vol.30 (2), p.136-143

2010

Volltextzugriff (PDF)

A multicenter evaluation of linezolid antimicrobial activity in North America

Diagnostic microbiology and infectious disease, 2002-05, Vol.43 (1), p.75-83

2002

Volltextzugriff (PDF)

Pharmacokinetics of BILR 355 after Multiple Oral Doses Coadministered with a Low Dose of Ritonavir

Antimicrobial Agents and Chemotherapy, 2009-01, Vol.53 (1), p.95-103

2009

Volltextzugriff (PDF)

New agents for Gram-positive bacteria

Current Opinion in Microbiology, 2000-10, Vol.3 (5), p.528-534

2000

Volltextzugriff (PDF)

Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada

Diagnostic microbiology and infectious disease, 1998-07, Vol.31 (3), p.437-451

1998

Volltextzugriff (PDF)

Fosamprenavir plus Ritonavir Increases Plasma Ketoconazole and Ritonavir Exposure, while Amprenavir Exposure Remains Unchanged

Antimicrobial Agents and Chemotherapy, 2007-08, Vol.51 (8), p.2982-2984

2007

Volltextzugriff (PDF)

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox® Antimicrobial Potency Study (ZAPS) in the United States

Diagnostic microbiology and infectious disease, 2001-05, Vol.40 (1), p.59-66

2001

Volltextzugriff (PDF)

Efficacy of a Methylphenidate Transdermal System Versus t.i.d. Methylphenidate in a Laboratory Setting

Journal of attention disorders, 2011-01, Vol.15 (1), p.28-35

2011

Volltextzugriff (PDF)

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia

Diagnostic microbiology and infectious disease, 2000-03, Vol.36 (3), p.145-158

2000

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients

Clinical therapeutics, 2001-08, Vol.23 (8), p.1231-1244

2001

Volltextzugriff (PDF)

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy

Journal of antimicrobial chemotherapy, 1999-03, Vol.43 Suppl A (suppl_1), p.55-63

1999

Volltextzugriff (PDF)

Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific

Journal of antimicrobial chemotherapy, 2003-02, Vol.51 (2), p.339-345

2003

Volltextzugriff (PDF)

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS)

The Brazilian journal of infectious diseases, 2002-06, Vol.6 (3), p.100-109

2002

Volltextzugriff (PDF)

Safety, Pharmacokinetic, Immunogenicity, and Pharmacodynamic Responses in Healthy Volunteers Following a Single Intravenous Injection of Purified Staphylococcal Protein A

Journal of clinical pharmacology, 2013-09, Vol.53 (9), p.909-918

2013

Volltextzugriff (PDF)

Absolute Bioavailability and Disposition of (−) and (+) 2′-Deoxy- 3′-Oxa-4′-Thiocytidine (dOTC) following Single Intravenous and Oral Doses of Racemic dOTC in Humans

Antimicrobial Agents and Chemotherapy, 2000-06, Vol.44 (6), p.1609-1615

2000

Volltextzugriff (PDF)

Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of BCH-10652 in Healthy Adult Males

Antimicrobial Agents and Chemotherapy, 2000-10, Vol.44 (10), p.2816-2823

2000

Volltextzugriff (PDF)

Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables

Journal of antimicrobial chemotherapy, 2000-03, Vol.45 (suppl-2), p.9-17

2000

Volltextzugriff (PDF)

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Clinical infectious diseases, 2014-11, Vol.59 (10), p.1420-1428

2014

Volltextzugriff (PDF)

Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

Journal of clinical pharmacology, 2015-04, Vol.55 (4), p.467-477

2015

Volltextzugriff (PDF)

Effect of Food on the Pharmacokinetics of (-) and (+) dOTC When Administered as an Oral Racemate

Journal of clinical pharmacology, 2002-06, Vol.42 (6), p.658-661

2002

Volltextzugriff (PDF)

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study

The Brazilian journal of infectious diseases, 2001-02, Vol.5 (1), p.21-31

2001

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(49)
Buchkapitel
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(38)
Science & Technology
(38)
Humans
(36)
Biological And Medical Sciences
(24)
Medical Sciences
(24)
Pharmacology & Pharmacy
(24)
Male
(21)
Microbiology
(21)
Pharmacology. Drug Treatments
(21)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(20)
Adult
(18)
Infectious Diseases
(17)
Middle Aged
(16)
Female
(15)
Antibacterial Agents
(12)
Area Under Curve
(11)
Microbial Sensitivity Tests
(11)
Anti-Bacterial Agents - Pharmacology
(9)
Aged
(8)
Antiviral Agents
(8)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of a State‐ and Use‐Dependent Nav1.7 Channel Blocker on Ambulatory Blood Pressure: A Randomized, Controlled Crossover Study

Pharmacodynamic Evaluation of Factors Associated with the Development of Bacterial Resistance in Acutely Ill Patients during Therapy

Safety and Pharmacokinetics of Bevirimat (PA-457), a Novel Inhibitor of Human Immunodeficiency Virus Maturation, in Healthy Volunteers

Multiple-dose pharmacokinetics and safety of bevirimat, a novel inhibitor of HIV maturation, in healthy volunteers

Effect of Telavancin on the Pharmacokinetics of the Cytochrome P450 3A Probe Substrate Midazolam: A Randomized, Double-Blind, Crossover Study in Healthy Subjects

A multicenter evaluation of linezolid antimicrobial activity in North America

Pharmacokinetics of BILR 355 after Multiple Oral Doses Coadministered with a Low Dose of Ritonavir

New agents for Gram-positive bacteria

Antimicrobial Activity of Quinupristin-Dalfopristin (RP 59500, Synercid®) Tested against Over 28,000 Recent Clinical Isolates from 200 Medical Centers in the United States and Canada

Fosamprenavir plus Ritonavir Increases Plasma Ketoconazole and Ritonavir Exposure, while Amprenavir Exposure Remains Unchanged

Multi-laboratory assessment of the linezolid spectrum of activity using the Kirby-Bauer disk diffusion method: Report of the Zyvox® Antimicrobial Potency Study (ZAPS) in the United States

Efficacy of a Methylphenidate Transdermal System Versus t.i.d. Methylphenidate in a Laboratory Setting

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia

Pharmacokinetics and pharmacodynamics of aztreonam and tobramycin in hospitalized patients

Antibiotic dosing issues in lower respiratory tract infection: population-derived area under inhibitory curve is predictive of efficacy

Multicentre evaluation of the in vitro activity of linezolid in the Western Pacific

Multicenter assessment of the linezolid spectrum and activity using the disk diffusion and Etest methods: report of the Zyvox(R) antimicrobial potency study in Latin America (LA-ZAPS)

Safety, Pharmacokinetic, Immunogenicity, and Pharmacodynamic Responses in Healthy Volunteers Following a Single Intravenous Injection of Purified Staphylococcal Protein A

Absolute Bioavailability and Disposition of (−) and (+) 2′-Deoxy- 3′-Oxa-4′-Thiocytidine (dOTC) following Single Intravenous and Oral Doses of Racemic dOTC in Humans

Safety, Tolerability, and Pharmacokinetics of Single Oral Doses of BCH-10652 in Healthy Adult Males

Comparison of the abilities of grepafloxacin and clarithromycin to eradicate potential bacterial pathogens from the sputa of patients with chronic bronchitis: influence of pharmacokinetic and pharmacodynamic variables

Clinical Assessment of Potential Drug Interactions of Faldaprevir, a Hepatitis C Virus Protease Inhibitor, With Darunavir/Ritonavir, Efavirenz, and Tenofovir

Interactions of the hepatitis C virus protease inhibitor faldaprevir with cytochrome P450 enzymes: In vitro and in vivo correlation

Effect of Food on the Pharmacokinetics of (-) and (+) dOTC When Administered as an Oral Racemate

Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study

Suchergebnisse filtern